Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val Gebski

Showing results (41-50 of 248) with videos related to

Pageof 25
Sort By:
Statistics in Medicine|September 5, 2002
On the issue of 'multiple' first failures in competing risks analysisBee-Choo Tai, Ian R White, Val Gebski, et al.
Australasian Radiology|December 4, 2003
Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancerAndrew Kneebone, Sandra Turner, Martin Berry, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
Selective mastectomy in the management of locally advanced breast cancerVerity Ahern, John Boyages, Val Gebski, et al.
Asia-Pacific Journal of Clinical Oncology|August 20, 2014
Epidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: a meta-analysisMalaka Ameratunga, Nick Pavlakis, Val Gebski, et al.
BMJ Evidence-Based Medicine|March 11, 2019
Cochrane vertebroplasty review misrepresented evidence for vertebroplasty with early intervention in severely affected patientsWilliam Clark, Paul Bird, Terrence Diamond, et al.
ANZ Journal of Surgery|March 22, 2005
Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?Michael J Veness, Gary J Morgan, Yasoda Sathiyaseelan, et al.
JNCI Cancer Spectrum|June 4, 2021
Response Rate and Survival at Key Timepoints With PD-1 Blockade vs Chemotherapy in PD-L1 Subgroups: Meta-Analysis of Metastatic NSCLC TrialsJohnathan Man, Jared Millican, Arthur Mulvey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 28, 2020
Long-term quality of life outcomes of women treated for early-stage endometrial cancerSaira Sanjida, Andreas Obermair, Val Gebski, et al.
Journal of the National Cancer Institute|January 5, 2006
Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspectiveVal Gebski, Marivic Lagleva, Anthony Keech, et al.
Obstetrics and Gynecology|June 8, 2002
Secondary cytoreductive surgery for recurrent epithelial ovarian cancerEng Hseon Tay, Peter T Grant, Val Gebski, et al.
Pageof 25

Showing results (41-50 of 248) with videos related to

Sort By:
Pageof 25
Statistics in Medicine|September 5, 2002
On the issue of 'multiple' first failures in competing risks analysisBee-Choo Tai, Ian R White, Val Gebski, et al.
Australasian Radiology|December 4, 2003
Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancerAndrew Kneebone, Sandra Turner, Martin Berry, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
Selective mastectomy in the management of locally advanced breast cancerVerity Ahern, John Boyages, Val Gebski, et al.
Asia-Pacific Journal of Clinical Oncology|August 20, 2014
Epidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: a meta-analysisMalaka Ameratunga, Nick Pavlakis, Val Gebski, et al.
BMJ Evidence-Based Medicine|March 11, 2019
Cochrane vertebroplasty review misrepresented evidence for vertebroplasty with early intervention in severely affected patientsWilliam Clark, Paul Bird, Terrence Diamond, et al.
ANZ Journal of Surgery|March 22, 2005
Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?Michael J Veness, Gary J Morgan, Yasoda Sathiyaseelan, et al.
JNCI Cancer Spectrum|June 4, 2021
Response Rate and Survival at Key Timepoints With PD-1 Blockade vs Chemotherapy in PD-L1 Subgroups: Meta-Analysis of Metastatic NSCLC TrialsJohnathan Man, Jared Millican, Arthur Mulvey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 28, 2020
Long-term quality of life outcomes of women treated for early-stage endometrial cancerSaira Sanjida, Andreas Obermair, Val Gebski, et al.
Journal of the National Cancer Institute|January 5, 2006
Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspectiveVal Gebski, Marivic Lagleva, Anthony Keech, et al.
Obstetrics and Gynecology|June 8, 2002
Secondary cytoreductive surgery for recurrent epithelial ovarian cancerEng Hseon Tay, Peter T Grant, Val Gebski, et al.
Pageof 25